ZenithBIO, LLC

Strategic Business Development



    ZenithBIO Successes Highlight Flexibility, Network & Breadth of Industry Experience

    • For a Specialty Pharma Client: Against the odds: Identified a viable P-3 clinical asset.
    • For a private biotech Client: Conducted in-depth KOL & clinician interviews that identified critical commercial end points for their clinical development program.
    • For a Drug Delivery Client: Pipeline analyses combining KOL interviews with market data increased valuation during M&A negotiations.
    • For Virtual Companies: Seamless interaction with other external consulting groups across the biopharma functional & commercial areas.


Therapeutic Areas: Broad Experience Across Specialty & Primary Care Conditions


  • AutoImmune & Inflammatory Diseases
  • Anti-Infectives
  • Cardiology: Acute & Chronic
  • CNS
  • Diabetes
  • Endocrine
  • GI
  • Oncology
  • Respiratory Diseases
  • Transplantation
  • Urology
  • Uveitis
  • Pain
  • Women’s health

Success stories after-the-fact look easy,
but the challenge is understanding the strategic potential of opportunities as well as the risks early on,
in order to optimize the value of deals, pipelines, and product launches.